Issue 29, 2020

Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents

Abstract

An efficient and practical method has been developed for the synthesis of steroidal imidazoheterocycles via cost-effective and environmentally benign FeCl3-catalyzed oxidative amination. A library of steroidal imidazo[1,2-a]pyridines was directly synthesized from readily available 2-aminopyridines and steroidal ketones in aerobic conditions. The synthesized compounds were screened for activity on human microsomal cytochrome P450s CYP7, CYP17 and CYP21. Antiproliferative activity of two lead compounds 3ia and 3la was additionally evaluated against the human MCF-7 (breast cancer), SKOV3 (ovarian cancer), and 22Rv1 (prostate cancer) cell lines. Steroidal imidazo[1,2-a]pyridine 3la which is a substrate molecule for CYP17A1 with IC50 = 1.7 μM (MCF-7), 3.0 (SKOV3), and 6.0 μM (22Rv1) has proved to be more active than reference drug cisplatin.

Graphical abstract: Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents

Supplementary files

Article information

Article type
Communication
Submitted
16 Jun 2020
Accepted
10 Jul 2020
First published
10 Jul 2020

Org. Biomol. Chem., 2020,18, 5571-5576

Fe(III)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents

S. Samanta, A. K. Ghosh, S. Ghosh, A. A. Ilina, Y. A. Volkova, I. V. Zavarzin, A. M. Scherbakov, D. I. Salnikova, Y. U. Dzichenka, A. B. Sachenko, V. Z. Shirinian and A. Hajra, Org. Biomol. Chem., 2020, 18, 5571 DOI: 10.1039/D0OB01241F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements